Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to FOLFOXIRI
Related studies linked through entity extraction aliases.
CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
- Status
- RECRUITING
- Phase
- PHASE3
Research on the Treatment of Metastatic Colon Cancer Patients Treated by FOLFOXIRI
- Status
- COMPLETED
- Phase
- N/A
Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels
- Status
- TERMINATED
- Phase
- PHASE2
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2